Oncologie

Use of Digital Health Technology to Enable Drug Development

Juin 2018 – American Society of Clinical Oncology Journal
Joyce F. Liu, Jung-min Lee, Ellie Strock, Ruth Phillips, Karine Mari, Bill Killiam, …

Vous souhaitez échanger
avec nos équipes

Contactez-nous

D’autres articles qui pourraient
vous intéresser

Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study 
Oncologie

Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study 

Primary efficacy analysis of a phase II study of neoadjuvant Bevacizumab, chemotherapy, and Trastuzumab in HER2-positive inflammatory breast cancer: BEVERLY 2 study
Oncologie

Primary efficacy analysis of a phase II study of neoadjuvant Bevacizumab, chemotherapy, and Trastuzumab in HER2-positive inflammatory breast cancer: BEVERLY 2 study

Surgical post-opérative complications in neoadjuvant treatment including Bevacizumab for HER2-positive inflammatory breast cancer: results from a phase II prospective trial
Oncologie

Surgical post-opérative complications in neoadjuvant treatment including Bevacizumab for HER2-positive inflammatory breast cancer: results from a phase II prospective trial